世界のPRRSワクチン市場2021-2026:生ワクチン、不活化ワクチン

LP Informationが発行した調査報告書(LPI21MY6857)
◆英語タイトル:Global PRRS Vaccines Market Growth 2021-2026
◆商品コード:LPI21MY6857
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年5月(※2024年版があります。お問い合わせください)
◆ページ数:160
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:産業機械
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

LPインフォメーション社の「PRRSワクチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、生ワクチン、不活化ワクチンなど、用途別には、政府入札、市場販売などにセグメント区分してまとめました。PRRSワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・PRRSワクチンの世界市場概要(サマリー)
・PRRSワクチンの企業別販売量・売上
・PRRSワクチンの企業別市場シェア
・PRRSワクチンの世界市場規模 2016年-2021年:種類別(生ワクチン、不活化ワクチン)
・PRRSワクチンの世界市場規模 2016年-2021年:用途別(政府入札、市場販売)
・PRRSワクチンの南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・PRRSワクチンのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・PRRSワクチンのヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・PRRSワクチンの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・PRRSワクチン市場の成長要因・課題・動向
・PRRSワクチンの世界市場予測 2021年-2026年
・PRRSワクチンの南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・PRRSワクチンのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・PRRSワクチンのヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・PRRSワクチンの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・PRRSワクチンの世界市場予測:種類別(生ワクチン、不活化ワクチン)
・PRRSワクチンの世界市場予測:用途別(政府入札、市場販売)
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of PRRS Vaccines will have significant change from previous year. By the most conservative estimates of global PRRS Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the PRRS Vaccines market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of PRRS Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Live Vaccines
Killed Vaccines

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Government Tender
Market Sales

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
CAHIC
Merial
MSD Animal Health
Chopper Biology
Ceva
ChengDu Tecbond
Veterinary
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
Zoetis

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global PRRS Vaccines Consumption 2016-2026
2.1.2 PRRS Vaccines Consumption CAGR by Region
2.2 PRRS Vaccines Segment by Type
2.2.1 Live Vaccines
2.2.2 Killed Vaccines
2.3 PRRS Vaccines Sales by Type
2.3.1 Global PRRS Vaccines Sales Market Share by Type (2016-2021)
2.3.2 Global PRRS Vaccines Revenue and Market Share by Type (2016-2021)
2.3.3 Global PRRS Vaccines Sale Price by Type (2016-2021)
2.4 PRRS Vaccines Segment by Application
2.4.1 Government Tender
2.4.2 Market Sales
2.5 PRRS Vaccines Sales by Application
2.5.1 Global PRRS Vaccines Sale Market Share by Application (2016-2021)
2.5.2 Global PRRS Vaccines Revenue and Market Share by Application (2016-2021)
2.5.3 Global PRRS Vaccines Sale Price by Application (2016-2021)

3 Global PRRS Vaccines by Company
3.1 Global PRRS Vaccines Sales Market Share by Company
3.1.1 Global PRRS Vaccines Sales by Company (2019-2021)
3.1.2 Global PRRS Vaccines Sales Market Share by Company (2019-2021)
3.2 Global PRRS Vaccines Revenue Market Share by Company
3.2.1 Global PRRS Vaccines Revenue by Company (2019-2021)
3.2.2 Global PRRS Vaccines Revenue Market Share by Company (2019-2021)
3.3 Global PRRS Vaccines Sale Price by Company
3.4 Global Manufacturers PRRS Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers PRRS Vaccines Product Location Distribution
3.4.2 Players PRRS Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 PRRS Vaccines by Region
4.1 Global PRRS Vaccines by Region
4.1.1 Global PRRS Vaccines Sales by Region
4.1.2 Global PRRS Vaccines Revenue by Region
4.2 Americas PRRS Vaccines Sales Growth
4.3 APAC PRRS Vaccines Sales Growth
4.4 Europe PRRS Vaccines Sales Growth
4.5 Middle East & Africa PRRS Vaccines Sales Growth

5 Americas
5.1 Americas PRRS Vaccines Sales by Country
5.1.1 Americas PRRS Vaccines Sales by Country (2016-2021)
5.1.2 Americas PRRS Vaccines Revenue by Country (2016-2021)
5.2 Americas PRRS Vaccines Sales by Type
5.3 Americas PRRS Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC PRRS Vaccines Sales by Region
6.1.1 APAC PRRS Vaccines Sales by Region (2016-2021)
6.1.2 APAC PRRS Vaccines Revenue by Region (2016-2021)
6.2 APAC PRRS Vaccines Sales by Type
6.3 APAC PRRS Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe PRRS Vaccines by Country
7.1.1 Europe PRRS Vaccines Sales by Country (2016-2021)
7.1.2 Europe PRRS Vaccines Revenue by Country (2016-2021)
7.2 Europe PRRS Vaccines Sales by Type
7.3 Europe PRRS Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa PRRS Vaccines by Country
8.1.1 Middle East & Africa PRRS Vaccines Sales by Country (2016-2021)
8.1.2 Middle East & Africa PRRS Vaccines Revenue by Country (2016-2021)
8.2 Middle East & Africa PRRS Vaccines Sales by Type
8.3 Middle East & Africa PRRS Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 PRRS Vaccines Distributors
10.3 PRRS Vaccines Customer

11 Global PRRS Vaccines Market Forecast
11.1 Global PRRS Vaccines Forecast by Region
11.1.1 Global PRRS Vaccines Forecast by Regions (2021-2026)
11.2.2 Global PRRS Vaccines Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global PRRS Vaccines Forecast by Type
11.7 Global PRRS Vaccines Forecast by Application

12 Key Players Analysis
12.1 CAHIC
12.1.1 CAHIC CAHIC Company Information
12.1.2 CAHIC PRRS Vaccines Product Offered
12.1.3 CAHIC PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 CAHIC Main Business Overview
12.1.5 CAHIC Latest Developments
12.2 Merial
12.2.1 Merial Company Information
12.2.2 Merial PRRS Vaccines Product Offered
12.2.3 Merial PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Merial Main Business Overview
12.2.5 Merial Latest Developments
12.3 MSD Animal Health
12.3.1 MSD Animal Health Company Information
12.3.2 MSD Animal Health PRRS Vaccines Product Offered
12.3.3 MSD Animal Health PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 MSD Animal Health Main Business Overview
12.3.5 MSD Animal Health Latest Developments
12.4 Chopper Biology
12.4.1 Chopper Biology Company Information
12.4.2 Chopper Biology PRRS Vaccines Product Offered
12.4.3 Chopper Biology PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Chopper Biology Main Business Overview
12.4.5 Chopper Biology Latest Developments
12.5 Ceva
12.5.1 Ceva Company Information
12.5.2 Ceva PRRS Vaccines Product Offered
12.5.3 Ceva PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Ceva Main Business Overview
12.5.5 Ceva Latest Developments
12.6 ChengDu Tecbond
12.6.1 ChengDu Tecbond Company Information
12.6.2 ChengDu Tecbond PRRS Vaccines Product Offered
12.6.3 ChengDu Tecbond PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 ChengDu Tecbond Main Business Overview
12.6.5 ChengDu Tecbond Latest Developments
12.7 Veterinary
12.7.1 Veterinary Company Information
12.7.2 Veterinary PRRS Vaccines Product Offered
12.7.3 Veterinary PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Veterinary Main Business Overview
12.7.5 Veterinary Latest Developments
12.8 Ringpu Biology
12.8.1 Ringpu Biology Company Information
12.8.2 Ringpu Biology PRRS Vaccines Product Offered
12.8.3 Ringpu Biology PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Ringpu Biology Main Business Overview
12.8.5 Ringpu Biology Latest Developments
12.9 Qilu Animal
12.9.1 Qilu Animal Company Information
12.9.2 Qilu Animal PRRS Vaccines Product Offered
12.9.3 Qilu Animal PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Qilu Animal Main Business Overview
12.9.5 Qilu Animal Latest Developments
12.10 DHN
12.10.1 DHN Company Information
12.10.2 DHN PRRS Vaccines Product Offered
12.10.3 DHN PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 DHN Main Business Overview
12.10.5 DHN Latest Developments
12.11 CAVAC
12.11.1 CAVAC Company Information
12.11.2 CAVAC PRRS Vaccines Product Offered
12.11.3 CAVAC PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 CAVAC Main Business Overview
12.11.5 CAVAC Latest Developments
12.12 Komipharm
12.12.1 Komipharm Company Information
12.12.2 Komipharm PRRS Vaccines Product Offered
12.12.3 Komipharm PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Komipharm Main Business Overview
12.12.5 Komipharm Latest Developments
12.13 Agrovet
12.13.1 Agrovet Company Information
12.13.2 Agrovet PRRS Vaccines Product Offered
12.13.3 Agrovet PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Agrovet Main Business Overview
12.13.5 Agrovet Latest Developments
12.14 Bioveta
12.14.1 Bioveta Company Information
12.14.2 Bioveta PRRS Vaccines Product Offered
12.14.3 Bioveta PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Bioveta Main Business Overview
12.14.5 Bioveta Latest Developments
12.15 Jinyu Bio-Technology
12.15.1 Jinyu Bio-Technology Company Information
12.15.2 Jinyu Bio-Technology PRRS Vaccines Product Offered
12.15.3 Jinyu Bio-Technology PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Jinyu Bio-Technology Main Business Overview
12.15.5 Jinyu Bio-Technology Latest Developments
12.16 Institutul Pasteur
12.16.1 Institutul Pasteur Company Information
12.16.2 Institutul Pasteur PRRS Vaccines Product Offered
12.16.3 Institutul Pasteur PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Institutul Pasteur Main Business Overview
12.16.5 Institutul Pasteur Latest Developments
12.17 MVP
12.17.1 MVP Company Information
12.17.2 MVP PRRS Vaccines Product Offered
12.17.3 MVP PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 MVP Main Business Overview
12.17.5 MVP Latest Developments
12.18 Tecon
12.18.1 Tecon Company Information
12.18.2 Tecon PRRS Vaccines Product Offered
12.18.3 Tecon PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 Tecon Main Business Overview
12.18.5 Tecon Latest Developments
12.19 Zoetis
12.19.1 Zoetis Company Information
12.19.2 Zoetis PRRS Vaccines Product Offered
12.19.3 Zoetis PRRS Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.19.4 Zoetis Main Business Overview
12.19.5 Zoetis Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. PRRS Vaccines Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Live Vaccines
Table 3. Major Players of Killed Vaccines
Table 4. Global PRRS Vaccines Sales by Type (2016-2021) & (K Units)
Table 5. Global PRRS Vaccines Sales Market Share by Type (2016-2021)
Table 6. Global PRRS Vaccines Revenue by Type (2016-2021) & ($ million)
Table 7. Global PRRS Vaccines Revenue Market Share by Type (2016-2021)
Table 8. Global PRRS Vaccines Sale Price by Type (2016-2021)
Table 9. Global PRRS Vaccines Sales by Application (2016-2021) & (K Units)
Table 10. Global PRRS Vaccines Sales Market Share by Application (2016-2021)
Table 11. Global PRRS Vaccines Value by Application (2016-2021)
Table 12. Global PRRS Vaccines Revenue Market Share by Application (2016-2021)
Table 13. Global PRRS Vaccines Sale Price by Application (2016-2021)
Table 14. Global PRRS Vaccines Sales by Company (2019-2021) & (K Units)
Table 15. Global PRRS Vaccines Sales Market Share by Company (2019-2021)
Table 16. Global PRRS Vaccines Revenue by Company (2019-2021) ($ Millions)
Table 17. Global PRRS Vaccines Revenue Market Share by Company (2019-2021)
Table 18. Global PRRS Vaccines Sale Price by Company (2019-2021)
Table 19. Key Manufacturers PRRS Vaccines Producing Area Distribution and Sales Area
Table 20. Players PRRS Vaccines Products Offered
Table 21. PRRS Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global PRRS Vaccines Sales by Region (2016-2021) (K Units)
Table 25. Global PRRS Vaccines Sales Market Share by Region (2016-2021)
Table 26. Global PRRS Vaccines Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global PRRS Vaccines Revenue Market Share by Region (2016-2021)
Table 28. Americas PRRS Vaccines Sales by Country (2016-2021) & (K Units)
Table 29. Americas PRRS Vaccines Sales Market Share by Country (2016-2021)
Table 30. Americas PRRS Vaccines Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas PRRS Vaccines Revenue Market Share by Country (2016-2021)
Table 32. Americas PRRS Vaccines Sales by Type (2016-2021) & (K Units)
Table 33. Americas PRRS Vaccines Sales Market Share by Type (2016-2021)
Table 34. Americas PRRS Vaccines Sales by Application (2016-2021) & (K Units)
Table 35. Americas PRRS Vaccines Sales Market Share by Application (2016-2021)
Table 36. APAC PRRS Vaccines Sales by Region (2016-2021) & (K Units)
Table 37. APAC PRRS Vaccines Sales Market Share by Region (2016-2021)
Table 38. APAC PRRS Vaccines Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC PRRS Vaccines Revenue Market Share by Region (2016-2021)
Table 40. APAC PRRS Vaccines Sales by Type (2016-2021) & (K Units)
Table 41. APAC PRRS Vaccines Sales Market Share by Type (2016-2021)
Table 42. APAC PRRS Vaccines Sales by Application (2016-2021) & (K Units)
Table 43. APAC PRRS Vaccines Sales Market Share by Application (2016-2021)
Table 44. Europe PRRS Vaccines Sales by Country (2016-2021) & (K Units)
Table 45. Europe PRRS Vaccines Sales Market Share by Country (2016-2021)
Table 46. Europe PRRS Vaccines Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe PRRS Vaccines Revenue Market Share by Country (2016-2021)
Table 48. Europe PRRS Vaccines Sales by Type (2016-2021) & (K Units)
Table 49. Europe PRRS Vaccines Sales Market Share by Type (2016-2021)
Table 50. Europe PRRS Vaccines Sales by Application (2016-2021) & (K Units)
Table 51. Europe PRRS Vaccines Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa PRRS Vaccines Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa PRRS Vaccines Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa PRRS Vaccines Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa PRRS Vaccines Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa PRRS Vaccines Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa PRRS Vaccines Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa PRRS Vaccines Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa PRRS Vaccines Sales Market Share by Application (2016-2021)
Table 60. Global PRRS Vaccines Sales Forecast by Type (2021-2026) & (K Units)
Table 61. Global PRRS Vaccines Sales Market Share Forecast by Type (2021-2026)
Table 62. Global PRRS Vaccines Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global PRRS Vaccines Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global PRRS Vaccines Sales Forecast by Application (2021-2026) & (K Units)
Table 65. Global PRRS Vaccines Sales Market Share Forecast by Application (2021-2026)
Table 66. Global PRRS Vaccines Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global PRRS Vaccines Revenue Market Share Forecast by Application (2021-2026)
Table 68. CAHIC Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 69. CAHIC PRRS Vaccines Product Offered
Table 70. CAHIC PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 71. CAHIC Main Business
Table 72. CAHIC Latest Developments
Table 73. Merial Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 74. Merial PRRS Vaccines Product Offered
Table 75. Merial PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 76. Merial Main Business
Table 77. Merial Latest Developments
Table 78. MSD Animal Health Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. MSD Animal Health PRRS Vaccines Product Offered
Table 80. MSD Animal Health PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 81. MSD Animal Health Main Business
Table 82. MSD Animal Health Latest Developments
Table 83. Chopper Biology Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Chopper Biology PRRS Vaccines Product Offered
Table 85. Chopper Biology PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 86. Chopper Biology Main Business
Table 87. Chopper Biology Latest Developments
Table 88. Ceva Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Ceva PRRS Vaccines Product Offered
Table 90. Ceva PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 91. Ceva Main Business
Table 92. Ceva Latest Developments
Table 93. ChengDu Tecbond Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. ChengDu Tecbond PRRS Vaccines Product Offered
Table 95. ChengDu Tecbond PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 96. ChengDu Tecbond Main Business
Table 97. ChengDu Tecbond Latest Developments
Table 98. Veterinary Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Veterinary PRRS Vaccines Product Offered
Table 100. Veterinary PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 101. Veterinary Main Business
Table 102. Veterinary Latest Developments
Table 103. Ringpu Biology Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Ringpu Biology PRRS Vaccines Product Offered
Table 105. Ringpu Biology PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 106. Ringpu Biology Main Business
Table 107. Ringpu Biology Latest Developments
Table 108. Qilu Animal Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Qilu Animal PRRS Vaccines Product Offered
Table 110. Qilu Animal PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 111. Qilu Animal Main Business
Table 112. Qilu Animal Latest Developments
Table 113. DHN Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. DHN PRRS Vaccines Product Offered
Table 115. DHN PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 116. DHN Main Business
Table 117. DHN Latest Developments
Table 118. CAVAC Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. CAVAC PRRS Vaccines Product Offered
Table 120. CAVAC PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 121. CAVAC Main Business
Table 122. CAVAC Latest Developments
Table 123. Komipharm Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. Komipharm PRRS Vaccines Product Offered
Table 125. Komipharm PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 126. Komipharm Main Business
Table 127. Komipharm Latest Developments
Table 128. Agrovet Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. Agrovet PRRS Vaccines Product Offered
Table 130. Agrovet PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 131. Agrovet Main Business
Table 132. Agrovet Latest Developments
Table 133. Bioveta Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. Bioveta PRRS Vaccines Product Offered
Table 135. Bioveta PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 136. Bioveta Main Business
Table 137. Bioveta Latest Developments
Table 138. Jinyu Bio-Technology Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139. Jinyu Bio-Technology PRRS Vaccines Product Offered
Table 140. Jinyu Bio-Technology PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 141. Jinyu Bio-Technology Main Business
Table 142. Jinyu Bio-Technology Latest Developments
Table 143. Institutul Pasteur Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 144. Institutul Pasteur PRRS Vaccines Product Offered
Table 145. Institutul Pasteur PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 146. Institutul Pasteur Main Business
Table 147. Institutul Pasteur Latest Developments
Table 148. MVP Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 149. MVP PRRS Vaccines Product Offered
Table 150. MVP PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 151. MVP Main Business
Table 152. MVP Latest Developments
Table 153. Tecon Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 154. Tecon PRRS Vaccines Product Offered
Table 155. Tecon PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 156. Tecon Main Business
Table 157. Tecon Latest Developments
Table 158. Zoetis Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 159. Zoetis PRRS Vaccines Product Offered
Table 160. Zoetis PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 161. Zoetis Main Business
Table 162. Zoetis Latest Developments
List of Figures
Figure 1. Picture of PRRS Vaccines
Figure 2. PRRS Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global PRRS Vaccines Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global PRRS Vaccines Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. PRRS Vaccines Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Live Vaccines
Figure 10. Product Picture of Killed Vaccines
Figure 11. Global PRRS Vaccines Sales Market Share by Type in 2020
Figure 12. Global PRRS Vaccines Revenue Market Share by Type (2016-2021)
Figure 13. PRRS Vaccines Consumed in Government Tender
Figure 14. Global PRRS Vaccines Market: Government Tender (2016-2021) & (K Units)
Figure 15. PRRS Vaccines Consumed in Market Sales
Figure 16. Global PRRS Vaccines Market: Market Sales (2016-2021) & (K Units)
Figure 17. Global PRRS Vaccines Sales Market Share by Application (2016-2021)
Figure 18. Global PRRS Vaccines Revenue Market Share by Application in 2020
Figure 19. Global PRRS Vaccines Revenue Market by Company in 2020 ($ Million)
Figure 20. Global PRRS Vaccines Revenue Market Share by Company in 2020
Figure 21. Global PRRS Vaccines Sales Market Share by Regions (2016-2021)
Figure 22. Global PRRS Vaccines Revenue Market Share by Region in 2020
Figure 23. Americas PRRS Vaccines Sales 2016-2021 (K Units)
Figure 24. Americas PRRS Vaccines Revenue 2016-2021 ($ Millions)
Figure 25. APAC PRRS Vaccines Sales 2016-2021 (K Units)
Figure 26. APAC PRRS Vaccines Revenue 2016-2021 ($ Millions)
Figure 27. Europe PRRS Vaccines Sales 2016-2021 (K Units)
Figure 28. Europe PRRS Vaccines Revenue 2016-2021 ($ Millions)
Figure 29. Middle East & Africa PRRS Vaccines Sales 2016-2021 (K Units)
Figure 30. Middle East & Africa PRRS Vaccines Revenue 2016-2021 ($ Millions)
Figure 31. Americas PRRS Vaccines Sales Market Share by Country in 2020
Figure 32. Americas PRRS Vaccines Revenue Market Share by Country in 2020
Figure 33. Americas PRRS Vaccines Sales Market Share by Type in 2020
Figure 34. Americas PRRS Vaccines Sales Market Share by Application in 2020
Figure 35. United States PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 36. Canada PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 37. Mexico PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 38. Brazil PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 39. APAC PRRS Vaccines Sales Market Share by Region in 2020
Figure 40. APAC PRRS Vaccines Revenue Market Share by Regions in 2020
Figure 41. APAC PRRS Vaccines Sales Market Share by Type in 2020
Figure 42. APAC PRRS Vaccines Sales Market Share by Application in 2020
Figure 43. China PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 44. Japan PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 45. Korea PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 46. Southeast Asia PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 47. India PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 48. Australia PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 49. Europe PRRS Vaccines Sales Market Share by Country in 2020
Figure 50. Europe PRRS Vaccines Revenue Market Share by Country in 2020
Figure 51. Europe PRRS Vaccines Sales Market Share by Type in 2020
Figure 52. Europe PRRS Vaccines Sales Market Share by Application in 2020
Figure 53. Germany PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 54. France PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 55. UK PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 56. Italy PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 57. Russia PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 58. Middle East & Africa PRRS Vaccines Sales Market Share by Country in 2020
Figure 59. Middle East & Africa PRRS Vaccines Revenue Market Share by Country in 2020
Figure 60. Middle East & Africa PRRS Vaccines Sales Market Share by Type in 2020
Figure 61. Middle East & Africa PRRS Vaccines Sales Market Share by Application in 2020
Figure 62. Egypt PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 63. South Africa PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 64. Israel PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 65. Turkey PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 66. GCC Country PRRS Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles


【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のPRRSワクチン市場2021-2026:生ワクチン、不活化ワクチン(Global PRRS Vaccines Market Growth 2021-2026)]についてメールでお問い合わせはこちらでお願いします。